Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Prescription medicine · generic available

Tiopronin

Drug class: Reducing and Complexing Thiol

The FDA’s “Established Pharmacologic Class”: the group of medicines that work in a similar way.

Official FDA data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the drug label, the NDC Directory, Drugs@FDA, recall reports and the drug shortage list. Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Tiopronin used for?
The FDA-approved label (Thiola, Mission Pharmacal Company, August 27, 2026) says: “THIOLA is indicated, in combination with high fluid intake, alkali, and diet modification, for the prevention of cystine stone formation in adults and pediatric patients 20 kg and greater with severe homozygous cystinuria, who are not responsive to these measures alone. …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Does Tiopronin have a boxed warning?
No. None of the 10 FDA labels we found for this medicine has a boxed warning.
Is there a shortage of Tiopronin?
No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
Has Tiopronin been recalled?
No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
Who makes Tiopronin?
8 companies list prescription products of Tiopronin in the FDA NDC Directory, including Mission Pharmacal Company, BioComp Pharma, Inc. and Teva Pharmaceuticals, Inc..

What Tiopronin is used for

Quoted from the “Indications and Usage” section of the FDA-approved label.

THIOLA is indicated, in combination with high fluid intake, alkali, and diet modification, for the prevention of cystine stone formation in adults and pediatric patients 20 kg and greater with severe homozygous cystinuria, who are not responsive to these measures alone. …

— FDA label: Thiola, Mission Pharmacal Company, effective August 27, 2026. Read the full label on DailyMed →

The FDA has 10 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

Boxed warning

A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.

The label quoted above has no boxed warning.

0 of 10 FDA labels for this medicine have a boxed warning.

Forms and how it is given

Dosage formsTablet, delayed release · Tablet, sugar coated
RouteOral
Prescription products16 in the FDA NDC Directory
Brand namesThiola Ec, Venxxiva, Thiola

Companies that list this medicine

Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.

FDA approval history

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
  • ANDA: Abbreviated New Drug Application: how a generic version is approved.
Brand and biologic applications
ApplicationSponsorApprovedLater changes approved
NDA019569
THIOLA
Mission PharmaAugust 11, 1988 3, latest June 28, 2019
2019: Labeling · 2001: Manufacturing (CMC) · 2000: Manufacturing (CMC)
NDA211843
THIOLA EC
Mission PharmacalJune 28, 2019 1, latest March 8, 2021
2021: Labeling

Generic approvals (5)

Shortage status

The FDA drug shortage list does not show these products.

FDA Drug Shortages database →

Recalls

No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.

Official identifiers

RxCUI (RxNorm)198287, 207840, 2178075, 2178077, 2178079, 2178081, 2702682, 2702684
SPL set ID of the quoted label494a714e-923c-cd57-df6c-12886afb265a
FDA labels (SPL)10
FDA applicationsNDA019569, NDA211843, 5 ANDA
Active ingredients (FDA)TIOPRONIN

Sources

  1. FDA-approved label on DailyMed (National Library of Medicine) — Thiola, Mission Pharmacal Company, effective August 27, 2026; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
  2. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026

openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →

Report an error → · Information for medicine makers